The US Food and Drug Administration has approved a new combination therapy for advanced melanoma and has advised physicians to test for certain genetic mutations before prescribing the drugs. Both treatments are marketed by Genentech (Roche). ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
